Author

Alejandra L Lorenzen

The University of Texas at San Antonio Health Science Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Afaf SalibaiD· 1 shared Amanda J. ClarkiD· 1 shared Anders Hayden BergiD· 1 shared Esmeralda Trevino· 1 shared Guanshi ZhangiD· 1 shared Jason C. O’ConnoriD· 1 shared Kumar SharmaiD· 1 shared Kyle Q. VuiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Afaf SalibaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Quinolinic acid metabolism may mitigate AKI to CKD transition

Marie Christelle Saadé, Afaf Saliba, Amanda J. Clark, Subrata Debnath, Shiqi Zhang, Nagarjunachary Ragi, Valerie Etzrodt, Rahil Alhumaidi, Kyle Q. Vu, Tao Yu, Esmeralda Trevino, Alejandra L Lorenzen, Guanshi Zhang, Anders Hayden Berg, Jason C. O’Connor, , Kumar Sharma

This study identifies quinolinic acid as a mediator of kidney injury and fibrosis, suggesting it as a potential therapeutic target for preventing AKI-to-CKD progression.

bioRxiv · Oct 10, 2025 · PreprintPathology